# AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2023-06-09
Category: NEWS
Category URL: https://financedigest.com/category/news
Meta Title: AstraZeneca signs $2 billion pact with Quell for cell therapies
Meta Description: AstraZeneca partners with Quell Therapeutics in a $2 billion deal to create revolutionary cell therapies for autoimmune diseases like type 1 diabetes and
URL: https://financedigest.com/astrazeneca-signs-2-billion-agreement-with-quell-to-develop-cell-therapieshtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/2023-06-09t080503z2lynxmpej58078rtroptp4astrazeneca-quell-therapeutics-autoimmune-1736813912196-compressed.jpg)

# AstraZeneca signs $2 billion agreement with Quell to develop cell therapies

(Reuters) – AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.

The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications, the drugmaker said in a statement.

UK-based Quell will receive $85 million upfront from AstraZeneca, and is also eligible to receive over $2 billion for further development and commercialisation milestones, the company added.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Rashmi Aich)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---